Squires et al. “Potent, selective inhibitors of Fibroblast Growth Factor Receptor define Fibroblast Growth Factor dependence in pre-clinical cancer models.” Molecular Cancer Therapeutics 10, no. 22 2011: 1542-1552. DOI: 10.1158/1535-7163.MCT-11-0426.
Squires et al. “Potent, selective inhibitors of Fibroblast Growth Factor Receptor define Fibroblast Growth Factor dependence in pre-clinical cancer models.” Molecular Cancer Therapeutics 10, no. 22 2011: 1542-1552. DOI: 10.1158/1535-7163.MCT-11-0426.
